← Leaderboards
Clare Felicity Malone
Dana-Farber Cancer Inst
$211,922
Attributed
$211,922
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $74.9K · FY2019–21$100K$75K$50K$25K$0
'19
'20
'21
Funding mix
By agency
NIH$211,922 · 1
By mechanism
F32$211,922 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Rani E George$9,003,170
- Jeffrey Wade Harper$36,219,392
- Steven P. Balk$19,509,335
- Daphne A. Haas-Kogan$5,585,485
- Kai W Wucherpfennig$37,935,181
Others in their field
Other Emerging Leaders on “Adult”
- Beth Baseler · Leidos Biomedical Research, Inc.$127,607,354
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$93,592,175
- Susan M Landau · University Of California Berkeley$47,252,026
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$42,295,422
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Evan Z Macosko · Broad Institute, Inc.$32,116,761
Research focus
AdultApoptosisAreaAtac-SeqAutomobile DrivingBiologyCancer Cell LineCell Cycle ArrestCell LineCellsCell SurvivalCessation Of LifeChildChip-SeqChromatinChromatin StructureClustered Regularly Interspaced Short Palindromic RepeatsCommon NeoplasmComplexCrispr/Cas TechnologyCrispr ScreenDependenceDisorder RiskAblation
Grant awards (3)
Elucidating the role of the SAGA complex in MYCN-amplified neuroblastoma$74,886
F32 · FY2021 · CA · contact PI
Elucidating the role of the SAGA complex in MYCN-amplified neuroblastoma$71,430
F32 · FY2020 · CA · contact PI
Elucidating the role of the SAGA complex in MYCN-amplified neuroblastoma$65,606
F32 · FY2019 · CA · contact PI